Drug application

MEPROBAMATE (MEPROBAMATE)

Drugs@FDA NDA 015417 · WEST WARD

Key facts

Drug name MEPROBAMATE
Active ingredients MEPROBAMATE
Application type NDA
Application number 015417
Company WEST WARD
Dosage forms TABLET, ORAL
Strength 400MG
Marketing status Discontinued
Reference listed drug No
Latest submission class Type 5 - New Formulation or New Manufacturer
Latest submission status date Dec 12, 1964

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications